<tt>
&lt;!DOCTYPE&nbsp;HTML&nbsp;PUBLIC&nbsp;&quot;-//W3C//DTD&nbsp;HTML&nbsp;4.01&nbsp;Transitional//EN&quot;<br>
&quot;http://www.w3.org/TR/html4/loose.dtd&quot;&gt;<br>
&lt;html&gt;<br>
&lt;head&gt;<br>
&lt;title&gt;Untitled&nbsp;Document&lt;/title&gt;<br>
&lt;meta&nbsp;http-equiv=&quot;Content-Type&quot;&nbsp;content=&quot;text/html;&nbsp;charset=iso-8859-1&quot;&gt;<br>
&lt;/head&gt;<br>
<br>
&lt;body&nbsp;bgcolor=&quot;#999999&quot;&gt;<br>
&lt;table&nbsp;width=&quot;750&quot;&nbsp;border=&quot;1&quot;&nbsp;align=&quot;center&quot;&nbsp;cellpadding=&quot;10&quot;&nbsp;cellspacing=&quot;0&quot;&nbsp;bordercolor=&quot;#000000&quot;&nbsp;background=&quot;http://www.a1info.net/images2/sausser/91404/bull.jpg&quot;&gt;<br>
&nbsp;&nbsp;&lt;tr&gt;<br>
&nbsp;&nbsp;&nbsp;&nbsp;&lt;td&gt;&lt;div&nbsp;align=&quot;left&quot;&gt;<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&lt;table&nbsp;width=&quot;563&quot;&nbsp;border=&quot;1&quot;&nbsp;cellspacing=&quot;0&quot;&nbsp;cellpadding=&quot;5&quot;&gt;<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&lt;tr&gt;<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&lt;td&nbsp;width=&quot;549&quot;&nbsp;bgcolor=&quot;#CCCCCC&quot;&gt;&lt;font&nbsp;face=&quot;Arial,&nbsp;Helvetica,&nbsp;sans-serif&quot;&gt;&lt;strong&gt;&lt;font&nbsp;color=&quot;#666666&quot;&gt;Company&nbsp;Name:&lt;/font&gt;&nbsp;Southwest&nbsp;Medical&nbsp;Solutions&lt;/strong&gt;&lt;br&gt;<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&lt;strong&gt;&lt;font&nbsp;color=&quot;#666666&quot;&gt;Stock&nbsp;Symbol:&lt;/font&gt;&lt;/strong&gt;&nbsp;&lt;strong&gt;SWMD&lt;/strong&gt;&lt;br&gt;<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&lt;strong&gt;&lt;font&nbsp;color=&quot;#666666&quot;&gt;Current&nbsp;Price:&lt;/font&gt;&lt;/strong&gt;&nbsp;&lt;strong&gt;.67&nbsp;cents&nbsp;&lt;/strong&gt;&lt;font&nbsp;size=&quot;2&quot;&gt;&lt;em&gt;&lt;strong&gt;(an&nbsp;increase&nbsp;of&nbsp;around&nbsp;10%&nbsp;since&nbsp;first&nbsp;issued&nbsp;at&nbsp;.60&nbsp;cents)&nbsp;&lt;/strong&gt;&lt;/em&gt;&lt;/font&gt;&lt;br&gt;<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&lt;strong&gt;&lt;font&nbsp;color=&quot;#666666&quot;&gt;Website:&lt;/font&gt;&lt;/strong&gt;&nbsp;&lt;a&nbsp;href='http://www.infoemail-web.com/080E1B1C1A17001B06131C11173206051B010617161F1306001B0A5C111D1F0E41454442470E400E400E404140434444440E08.aspx'&gt;&lt;strong&gt;www.swmsinc.com&nbsp;&lt;/strong&gt;&lt;/a&gt;&lt;/font&gt;&lt;/td&gt;<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&lt;/tr&gt;<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&lt;/table&gt;<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&lt;p&gt;&lt;font&nbsp;size=&quot;2&quot;&gt;&lt;strong&gt;&lt;font&nbsp;size=&quot;5&quot;&nbsp;face=&quot;Arial,&nbsp;Helvetica,&nbsp;sans-serif&quot;&gt;Breaking&nbsp;News:&nbsp;SWMD&nbsp;Impacts&nbsp;Health&nbsp;Care&nbsp;Costs&lt;/font&gt;&lt;/strong&gt;&lt;/font&gt;&lt;/p&gt;<br>
&nbsp;&nbsp;&nbsp;&nbsp;&lt;/div&gt;<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&lt;table&nbsp;width=&quot;700&quot;&nbsp;border=&quot;1&quot;&nbsp;align=&quot;center&quot;&nbsp;cellpadding=&quot;10&quot;&nbsp;cellspacing=&quot;0&quot;&gt;<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&lt;tr&gt;<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&lt;td&nbsp;bgcolor=&quot;#FFFFFF&quot;&gt;&lt;p&gt;&lt;font&nbsp;size=&quot;2&quot;&nbsp;face=&quot;Arial,&nbsp;Helvetica,&nbsp;sans-serif&quot;&gt;SWMD&nbsp;has&nbsp;recently&nbsp;acquired&nbsp;the&nbsp;exclusive&nbsp;rights&nbsp;to&nbsp;manufacture,&nbsp;market,&nbsp;and&nbsp;otherwise&nbsp;exploit&nbsp;Labguard&nbsp;Accucheck&amp;trade;,&nbsp;a&nbsp;technologically&nbsp;advanced&nbsp;device&nbsp;that&nbsp;is&nbsp;expected&nbsp;to&nbsp;significantly&nbsp;ease&nbsp;the&nbsp;task&nbsp;of&nbsp;on-site&nbsp;collection&nbsp;and&nbsp;testing,&nbsp;thus&nbsp;providing&nbsp;the&nbsp;highest&nbsp;level&nbsp;of&nbsp;safety&nbsp;and&nbsp;quickest&nbsp;possible&nbsp;results&nbsp;for&nbsp;the&nbsp;large&nbsp;and&nbsp;growing&nbsp;on-site&nbsp;diagnostic&nbsp;testing/screening&nbsp;market.&nbsp;Furthermore,&nbsp;its&nbsp;innovative&nbsp;Test&nbsp;Report&nbsp;Grid&amp;trade;&nbsp;technology&nbsp;is&nbsp;significantly&nbsp;less&nbsp;expensive&nbsp;than&nbsp;the&nbsp;nearest&nbsp;comparable&nbsp;product.&nbsp;The&nbsp;LabGuard&nbsp;Accucheck&nbsp;system&nbsp;is&nbsp;expecting&nbsp;to&nbsp;market&nbsp;launch&nbsp;in&nbsp;the&nbsp;4th&nbsp;Quarter&nbsp;of&nbsp;this&nbsp;year.&lt;/font&gt;&lt;/p&gt;<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&lt;p&nbsp;align=&quot;justify&quot;&gt;&lt;font&nbsp;size=&quot;2&quot;&nbsp;face=&quot;Arial,&nbsp;Helvetica,&nbsp;sans-serif&quot;&gt;Did&nbsp;you&nbsp;know&nbsp;that&nbsp;an&nbsp;estimated&nbsp;14.8&nbsp;million&nbsp;Americans&nbsp;are&nbsp;currently&nbsp;using&nbsp;drugs?&nbsp;Not&nbsp;considering&nbsp;the&nbsp;11%&nbsp;of&nbsp;those&nbsp;who&nbsp;are&nbsp;between&nbsp;the&nbsp;age&nbsp;of&nbsp;12&nbsp;and&nbsp;17,&nbsp;there&nbsp;is&nbsp;an&nbsp;estimated&nbsp;12.3&nbsp;million&nbsp;current&nbsp;adult&nbsp;illicit&nbsp;drug&nbsp;users.&nbsp;Now&nbsp;what&nbsp;you&nbsp;may&nbsp;not&nbsp;know&nbsp;is&nbsp;that&nbsp;9.4&nbsp;million&nbsp;or&nbsp;77%&nbsp;of&nbsp;them&nbsp;work,&nbsp;making&nbsp;the&nbsp;vast&nbsp;majority&nbsp;of&nbsp;drug&nbsp;users&nbsp;in&nbsp;the&nbsp;U.S.&nbsp;employees.&nbsp;Threatening&nbsp;to&nbsp;jeopardize&nbsp;the&nbsp;safety&nbsp;of&nbsp;co-workers,&nbsp;customers&nbsp;and&nbsp;children,&nbsp;it&nbsp;is&nbsp;no&nbsp;wonder&nbsp;large&nbsp;organizations&nbsp;across&nbsp;America&nbsp;are&nbsp;taking&nbsp;important&nbsp;steps&nbsp;to&nbsp;create&nbsp;effective&nbsp;drug&nbsp;free&nbsp;environments,&nbsp;opening&nbsp;the&nbsp;doors&nbsp;to&nbsp;an&nbsp;explosive&nbsp;market&nbsp;for&nbsp;on-site&nbsp;testing&nbsp;of&nbsp;employees,&nbsp;job&nbsp;applicants,&nbsp;military&nbsp;personnel,&nbsp;public&nbsp;service&nbsp;workers,&nbsp;prison&nbsp;inmates&nbsp;and&nbsp;parolees,&nbsp;students&nbsp;&amp;amp;&nbsp;athletes,&nbsp;over&nbsp;the&nbsp;past&nbsp;decade.&lt;/font&gt;&lt;/p&gt;<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&lt;p&nbsp;align=&quot;justify&quot;&gt;&nbsp;&lt;font&nbsp;size=&quot;2&quot;&nbsp;face=&quot;Arial,&nbsp;Helvetica,&nbsp;sans-serif&quot;&gt;Designed&nbsp;to&nbsp;answer&nbsp;the&nbsp;demands&nbsp;of&nbsp;the&nbsp;healthcare&nbsp;industry&nbsp;for&nbsp;improvements,&nbsp;here&nbsp;are&nbsp;some&nbsp;other&nbsp;technical&nbsp;specifications&nbsp;provided&nbsp;by&nbsp;LabGuard&nbsp;Accucheck:&lt;/font&gt;<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&lt;ul&gt;<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&lt;li&gt;&lt;font&nbsp;size=&quot;2&quot;&nbsp;face=&quot;Arial,&nbsp;Helvetica,&nbsp;sans-serif&quot;&gt;Simultaneous&nbsp;detection&nbsp;of&nbsp;multiple&nbsp;drugs&nbsp;in&nbsp;under&nbsp;5&nbsp;minutes&nbsp;&lt;/font&gt;&lt;/li&gt;<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&lt;li&gt;&lt;font&nbsp;size=&quot;2&quot;&nbsp;face=&quot;Arial,&nbsp;Helvetica,&nbsp;sans-serif&quot;&gt;Integrated&nbsp;collection&nbsp;and&nbsp;testing&nbsp;device&nbsp;for&nbsp;every&nbsp;sample&nbsp;&lt;/font&gt;&lt;/li&gt;<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&lt;li&gt;&lt;font&nbsp;size=&quot;2&quot;&nbsp;face=&quot;Arial,&nbsp;Helvetica,&nbsp;sans-serif&quot;&gt;Sterile&nbsp;sample&nbsp;and&nbsp;reagent/fluid-free&nbsp;handling&nbsp;&lt;/font&gt;&lt;/li&gt;<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&lt;li&gt;&lt;font&nbsp;size=&quot;2&quot;&nbsp;face=&quot;Arial,&nbsp;Helvetica,&nbsp;sans-serif&quot;&gt;Room&nbsp;temperature&nbsp;storage&nbsp;&lt;/font&gt;&lt;/li&gt;<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&lt;li&gt;&lt;font&nbsp;size=&quot;2&quot;&nbsp;face=&quot;Arial,&nbsp;Helvetica,&nbsp;sans-serif&quot;&gt;Clear&nbsp;positive/negative&nbsp;results&lt;/font&gt;&lt;/li&gt;<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&lt;li&gt;&lt;font&nbsp;size=&quot;2&quot;&nbsp;face=&quot;Arial,&nbsp;Helvetica,&nbsp;sans-serif&quot;&gt;Non-Leak-Spill-proof&nbsp;container&lt;/font&gt;&lt;/li&gt;<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&lt;/ul&gt;<br>
<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&lt;p&nbsp;align=&quot;justify&quot;&gt;&lt;font&nbsp;size=&quot;2&quot;&nbsp;face=&quot;Arial,&nbsp;Helvetica,&nbsp;sans-serif&quot;&gt;Now&nbsp;for&nbsp;what&nbsp;we&nbsp;believe&nbsp;is&nbsp;one&nbsp;of&nbsp;the&nbsp;most&nbsp;exciting&nbsp;prospects&nbsp;for&nbsp;SWMD!&nbsp;We&nbsp;are&nbsp;referring&nbsp;to&nbsp;its&nbsp;easy-to-use,&nbsp;diagnostic&nbsp;testing&nbsp;kits&nbsp;for&nbsp;in-home&nbsp;testing&nbsp;for&nbsp;the&nbsp;presence&nbsp;of&nbsp;a&nbsp;wide&nbsp;range&nbsp;of&nbsp;substances&nbsp;and&nbsp;diseases,&nbsp;including&nbsp;Cholesterol,&nbsp;Diabetes&nbsp;Diseases,&nbsp;Alcohol&nbsp;Use,&nbsp;Allergy/Mold,&nbsp;Drug&nbsp;Use,&nbsp;Hazardous&nbsp;Chemicals,&nbsp;HIV/Aids,&nbsp;Hormones,&nbsp;Infertility,&nbsp;Menopause,&nbsp;Thyroid&nbsp;and&nbsp;Tobacco&nbsp;Use.&nbsp;This&nbsp;is&nbsp;significant&nbsp;because&nbsp;it&nbsp;allows&nbsp;for&nbsp;individuals&nbsp;and&nbsp;companies&nbsp;who&nbsp;already&nbsp;are&nbsp;experiencing&nbsp;high&nbsp;healthcare&nbsp;cost&amp;rsquo;s&nbsp;to&nbsp;save&nbsp;on&nbsp;expensive&nbsp;testing&nbsp;procedures&nbsp;issued&nbsp;by&nbsp;their&nbsp;physicians&nbsp;and&nbsp;associated&nbsp;laboratories.&nbsp;It&nbsp;also&nbsp;can&nbsp;potentially&nbsp;save&nbsp;lives!!&nbsp;In&nbsp;addition&nbsp;we&nbsp;feel&nbsp;these&nbsp;home&nbsp;diagnostic&nbsp;tests&nbsp;will&nbsp;become&nbsp;increasingly&nbsp;attractive&nbsp;over&nbsp;time&nbsp;adding&nbsp;to&nbsp;Southwest&nbsp;Medicals&nbsp;top&nbsp;and&nbsp;bottom&nbsp;line&nbsp;growth.&nbsp;&lt;/font&gt;&lt;/p&gt;<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&lt;p&nbsp;align=&quot;justify&quot;&gt;&lt;font&nbsp;size=&quot;2&quot;&nbsp;face=&quot;Arial,&nbsp;Helvetica,&nbsp;sans-serif&quot;&gt;We&nbsp;feel&nbsp;SWMD&nbsp;has&nbsp;a&nbsp;business&nbsp;model&nbsp;that&nbsp;makes&nbsp;sense&nbsp;and&nbsp;the&nbsp;vision&nbsp;to&nbsp;position&nbsp;itself&nbsp;in&nbsp;the&nbsp;future?&amp;rdquo;&nbsp;Keep&nbsp;your&nbsp;eyes&nbsp;peeled&nbsp;for&nbsp;any&nbsp;future&nbsp;developments&nbsp;as&nbsp;it&nbsp;could&nbsp;have&nbsp;a&nbsp;significant&nbsp;impact&nbsp;on&nbsp;SouthWest&nbsp;Medicals&nbsp;(SWMD)&nbsp;stock&nbsp;valuation...........&lt;/font&gt;&lt;/p&gt;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&lt;/td&gt;<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&lt;/tr&gt;<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&lt;/table&gt;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&lt;p&gt;&amp;nbsp;&lt;/p&gt;<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&lt;p&gt;&lt;font&nbsp;size=&quot;1&quot;&gt;Disclaimer:&lt;br&gt;<br>
&lt;/font&gt;&lt;font&nbsp;size=&quot;1&quot;&gt;Information&nbsp;within&nbsp;this&nbsp;email&nbsp;contains&nbsp;&quot;forward&nbsp;looking&nbsp;statements&quot;&nbsp;within&nbsp;the&nbsp;meaning&nbsp;of&nbsp;Section&nbsp;27A&nbsp;of&nbsp;the&nbsp;Securities&nbsp;Act&nbsp;of&nbsp;1933&nbsp;and&nbsp;Section&nbsp;21B&nbsp;of&nbsp;the&nbsp;Securities&nbsp;Exchange&nbsp;Act&nbsp;of&nbsp;1934.&nbsp;Any&nbsp;statements&nbsp;that&nbsp;express&nbsp;or&nbsp;involve&nbsp;discussions&nbsp;with&nbsp;respect&nbsp;to&nbsp;predictions,&nbsp;goals,&nbsp;expectations,&nbsp;beliefs,&nbsp;plans,&nbsp;projections,&nbsp;objectives,&nbsp;assumptions&nbsp;or&nbsp;future&nbsp;events&nbsp;or&nbsp;performance&nbsp;are&nbsp;not&nbsp;statements&nbsp;of&nbsp;historical&nbsp;fact&nbsp;and&nbsp;may&nbsp;be&nbsp;&quot;forward&nbsp;looking&nbsp;statements.&quot;&nbsp;&lt;/font&gt;&lt;/p&gt;<br>
&lt;p&gt;&lt;font&nbsp;size=&quot;1&quot;&gt;Forward&nbsp;looking&nbsp;statements&nbsp;are&nbsp;based&nbsp;on&nbsp;expectations,&nbsp;estimates&nbsp;and&nbsp;projections&nbsp;at&nbsp;the&nbsp;time&nbsp;the&nbsp;statements&nbsp;are&nbsp;made&nbsp;that&nbsp;involve&nbsp;a&nbsp;number&nbsp;of&nbsp;risks&nbsp;and&nbsp;uncertainties&nbsp;which&nbsp;could&nbsp;cause&nbsp;actual&nbsp;results&nbsp;or&nbsp;events&nbsp;to&nbsp;differ&nbsp;materially&nbsp;from&nbsp;those&nbsp;presently&nbsp;anticipated.&nbsp;Forward&nbsp;looking&nbsp;statements&nbsp;in&nbsp;this&nbsp;action&nbsp;may&nbsp;be&nbsp;identified&nbsp;through&nbsp;the&nbsp;use&nbsp;of&nbsp;words&nbsp;such&nbsp;as:&nbsp;&quot;projects&quot;,&nbsp;&quot;foresee&quot;,&nbsp;&quot;expects&quot;,&nbsp;&quot;estimates,&quot;&nbsp;&quot;believes,&quot;&nbsp;&quot;understands&quot;&nbsp;&quot;will,&quot;&nbsp;&quot;part&nbsp;of:&nbsp;&quot;anticipates,&quot;&nbsp;or&nbsp;that&nbsp;by&nbsp;statements&nbsp;indicating&nbsp;certain&nbsp;actions&nbsp;&quot;may,&quot;&nbsp;&quot;could,&quot;&nbsp;or&nbsp;&quot;might&quot;&nbsp;occur.&nbsp;All&nbsp;information&nbsp;provided&nbsp;within&nbsp;this&nbsp;email&nbsp;pertaining&nbsp;to&nbsp;investing,&nbsp;stocks,&nbsp;securities&nbsp;must&nbsp;be&nbsp;understood&nbsp;as&nbsp;information&nbsp;provided&nbsp;and&nbsp;not&nbsp;investment&nbsp;advice.&nbsp;we&nbsp;advise&nbsp;all&nbsp;readers&nbsp;and&nbsp;subscribers&nbsp;to&nbsp;seek&nbsp;advice&nbsp;from&nbsp;a&nbsp;registered&nbsp;professional&nbsp;securities&nbsp;representative&nbsp;before&nbsp;deciding&nbsp;to&nbsp;trade&nbsp;in&nbsp;stocks&nbsp;featured&nbsp;within&nbsp;this&nbsp;email.&nbsp;None&nbsp;of&nbsp;the&nbsp;material&nbsp;within&nbsp;this&nbsp;report&nbsp;shall&nbsp;be&nbsp;construed&nbsp;as&nbsp;any&nbsp;kind&nbsp;of&nbsp;investment&nbsp;advice.&nbsp;Please&nbsp;have&nbsp;in&nbsp;mind!&nbsp;that&nbsp;the&nbsp;interpretation&nbsp;of&nbsp;the&nbsp;witer&nbsp;of&nbsp;this&nbsp;newsletter&nbsp;about&nbsp;the&nbsp;news&nbsp;published&nbsp;by&nbsp;the&nbsp;company&nbsp;does&nbsp;not&nbsp;represent&nbsp;the&nbsp;company&nbsp;official&nbsp;statement&nbsp;and&nbsp;in&nbsp;fact&nbsp;may&nbsp;differ&nbsp;from&nbsp;the&nbsp;real&nbsp;meaning&nbsp;of&nbsp;what&nbsp;the&nbsp;news&nbsp;release&nbsp;meant&nbsp;to&nbsp;say.&nbsp;Please&nbsp;read&nbsp;the&nbsp;news&nbsp;release&nbsp;by&nbsp;yourself&nbsp;and&nbsp;judge&nbsp;by&nbsp;yourself&nbsp;about&nbsp;the&nbsp;details&nbsp;in&nbsp;it.&nbsp;&lt;/font&gt;&lt;/p&gt;<br>
&lt;p&gt;&lt;font&nbsp;size=&quot;1&quot;&gt;Readers&nbsp;of&nbsp;this&nbsp;publication&nbsp;are&nbsp;cautioned&nbsp;not&nbsp;to&nbsp;place&nbsp;undue&nbsp;reliance&nbsp;on&nbsp;forward-looking&nbsp;statements,&nbsp;which&nbsp;are&nbsp;based&nbsp;on&nbsp;certain&nbsp;assumptions&nbsp;and&nbsp;expectations&nbsp;involving&nbsp;various&nbsp;risks&nbsp;and&nbsp;uncertainties&nbsp;that&nbsp;could&nbsp;cause&nbsp;results&nbsp;to&nbsp;differ&nbsp;materially&nbsp;from&nbsp;those&nbsp;set&nbsp;forth&nbsp;in&nbsp;the&nbsp;forward-&nbsp;looking&nbsp;statements.&nbsp;&lt;/font&gt;&lt;/p&gt;<br>
&lt;p&gt;&lt;font&nbsp;size=&quot;1&quot;&gt;Please&nbsp;be&nbsp;advised&nbsp;that&nbsp;nothing&nbsp;within&nbsp;this&nbsp;email&nbsp;shall&nbsp;constitute&nbsp;a&nbsp;solicitation&nbsp;or&nbsp;an&nbsp;offer&nbsp;to&nbsp;buy&nbsp;or&nbsp;sell&nbsp;any&nbsp;security&nbsp;mentioned&nbsp;herein.&nbsp;This&nbsp;newsletter&nbsp;is&nbsp;neither&nbsp;a&nbsp;registered&nbsp;investment&nbsp;advisor&nbsp;nor&nbsp;affiliated&nbsp;with&nbsp;any&nbsp;broker&nbsp;or&nbsp;dealer.&nbsp;All&nbsp;statements&nbsp;made&nbsp;are&nbsp;our&nbsp;express&nbsp;opinion&nbsp;only&nbsp;and&nbsp;should&nbsp;be&nbsp;treated&nbsp;as&nbsp;such.&nbsp;We&nbsp;may&nbsp;own,&nbsp;buy&nbsp;and&nbsp;sell&nbsp;any&nbsp;securities&nbsp;mentioned&nbsp;at&nbsp;any&nbsp;time.&nbsp;This&nbsp;report&nbsp;includes&nbsp;forward-looking&nbsp;statements&nbsp;within&nbsp;the&nbsp;meaning&nbsp;of&nbsp;The&nbsp;Private&nbsp;Securities&nbsp;Litigation&nbsp;Reform&nbsp;Act&nbsp;of&nbsp;1995.&nbsp;These&nbsp;statements&nbsp;may&nbsp;include&nbsp;terms&nbsp;as&nbsp;&quot;expect&quot;,&nbsp;&quot;believe&quot;,&nbsp;&quot;may&quot;,&nbsp;&quot;will&quot;,&nbsp;&quot;move&amp;#148;,&amp;#148;&nbsp;undervalued&quot;&nbsp;and&nbsp;&quot;intend&quot;&nbsp;or&nbsp;similar&nbsp;terms.&nbsp;This&nbsp;newsletter&nbsp;was&nbsp;paid&nbsp;$5000&nbsp;from&amp;nbsp;a&nbsp;third&nbsp;party&nbsp;to&nbsp;send&nbsp;this&nbsp;report.&nbsp;PLEASE&nbsp;DO&nbsp;YOUR&nbsp;OWN&nbsp;DUE&nbsp;DILIGENCE&nbsp;BEFORE&nbsp;INVESTING&nbsp;IN&nbsp;ANY&nbsp;PROFILED&nbsp;COMPANY.&nbsp;You&nbsp;may&nbsp;lose&nbsp;money&nbsp;from&nbsp;investing&nbsp;in&nbsp;Penny&nbsp;Stocks&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;<br>
&nbsp;&nbsp;&lt;/tr&gt;<br>
&lt;/table&gt;<br>
&lt;br&gt;&lt;br&gt;&lt;table&nbsp;width='500'&nbsp;border='0'&nbsp;align='center'&nbsp;cellpadding='2'&nbsp;cellspacing='3'&gt;&lt;tr&gt;&lt;td&nbsp;align='center'&gt;&nbsp;&lt;p&nbsp;align='center'&gt;<br>
&lt;div&nbsp;align='center'&gt;&lt;a&nbsp;href='http://www.infoemail-web.com/080E1B1C1A17001B06131C11173206051B010617161F1306001B0A5C111D1F0E41454442470E400E08.aspx'&gt;&lt;img&nbsp;src='http://www.infoemail-web.com/img.gif'&nbsp;width='531'&nbsp;height='80'&nbsp;border='0'&gt;&lt;/a&gt;<br>
&lt;font&nbsp;size='1'&nbsp;face='Arial,&nbsp;Helvetica,&nbsp;sans-serif'&gt;&lt;br&gt;&lt;img&nbsp;src='http://www.infoemail-web.com/080E1B1C1A17001B06131C11173206051B010617161F1306001B0A5C111D1F0E41454442470E400E430E420E08.aspx'&gt;<br>
&lt;/font&gt;&lt;font&nbsp;color=&quot;#000000&quot;&nbsp;face=&quot;arial,&nbsp;verdana&quot;&nbsp;size=&quot;2&quot;&gt;SW&nbsp;Medical&nbsp;&amp;#183;&nbsp;13014&nbsp;N.&nbsp;Dale&nbsp;Mabry&nbsp;&amp;#183;&nbsp;Tampa,&nbsp;FL&nbsp;33618&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/body&gt;<br>
&lt;/html&gt;<br>
<br>

</tt>
